Infectious Diseases News and Research

RSS

Increased pneumonia rates after Japan earthquake

Significantly increased rates of pneumonia and related deaths were seen after the 2011 Earthquake and Tsunami in Tohoku, Japan, report researchers.

5 Mar 2013

Discovery provides clues for potentially eliminating HIV infection in children

A two-year-old child born with HIV infection and treated with antiretroviral drugs beginning in the first days of life no longer has detectable levels of virus using conventional testing despite not taking HIV medication for 10 months, according to findings presented today at the Conference on Retroviruses and Opportunistic Infections in Atlanta.

5 Mar 2013

HIV might promote aging and disease progression in people with HCV, study results suggest

Infectious disease experts at Johns Hopkins have found that among people infected with the hepatitis C virus, co-infection with HIV, speeds damage and scarring of liver tissue by almost a decade.

5 Mar 2013

Sanford-Burnham enters into partnership to test furin for treatment of dengue fever

Sanford-Burnham Medical Research Institute and 60- Pharmaceuticals, LLC, have entered into a partnership to test furin, a human proteinase, as a drug target for the treatment of dengue fever, one of the most common infectious diseases in the tropics and subtropics.

5 Mar 2013

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Three antiretroviral-based strategies intended to prevent HIV infection among women did not prove effective in a major clinical trial in Africa.

5 Mar 2013

Sanford Health announces new limb preservation program

Sanford Health announces a new limb preservation program, Sanford Limb Preservation Center. The center specializes in treating lower extremity wounds in patients at high risk of amputation and compromised leg and toe function, particularly those with diabetes and peripheral arterial disease.

5 Mar 2013

Researchers identify smoking gun for environmental exposures to affect future generations

Grandmother's cigarette smoking could be responsible for her grandchild's asthma, and the recent discovery of this multi-generational transmission of disease suggests the environmental factors experienced today could determine the health of family members for generations to come, two Los Angeles Biomedical Research Institute (LA BioMed) lead researchers write in the March edition of Review of Obstetrics & Gynecology.

5 Mar 2013

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

Interim study results from STARTversoTM 4 presented today at CROI+ show that 80 percent of hepatitis C (HCV) patients also infected with HIV achieved early treatment success with faldaprevir (BI 201335) combined with pegylated interferon and ribavirin (PegIFN/RBV).

5 Mar 2013

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Pfizer Inc. presented today the results from a Phase 3 study demonstrating the immunogenicity, tolerability and safety of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine Diphtheria CRM197 Protein)in adults infected with human immunodeficiency virus (HIV).

5 Mar 2013

Idera announces new data from IMO-3100 and IMO-8400 preclinical study on psoriasis

Idera Pharmaceuticals, Inc. today announced the presentation of new data showing that its selective Toll-like receptor antagonists, IMO-3100 and IMO-8400, normalized the gene expression of important cytokines in a preclinical study of skin inflammation that is commonly used as a model of psoriasis.

4 Mar 2013

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

Amoxicillin is a broad spectrum penicillin, and in the UK is one of the most frequently used antibiotics. It is commonly used either on its own or, where there are particular concerns about resistance, in combination as Co-amoxiclav (as Amoxicillin-clavulanic acid) which extends its anti-bacterial spectrum.

1 Mar 2013

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the company's late-stage antibiotic candidate, ceftolozane/tazobactam, as a Qualified Infectious Disease Product (QIDP) for the indications of Hospital-Acquired Bacterial Pneumonia (HABP)/Ventilator-Associated Bacterial Pneumonia (VABP) and Complicated Urinary Tract Infections (cUTI).

1 Mar 2013

Griffith University's Institute for Glycomics launches human trials for Streptococcus A vaccine

Griffith University's Institute for Glycomics has launched human trials for a vaccine against Streptococcus A, the germ that causes rheumatic fever.

1 Mar 2013

Steroids may reduce length of hospital stay in patients with pneumonia

Patients with pneumonia may spend fewer days in the hospital if they are given steroids along with antibiotics and supportive care. That's the finding of a Mayo Clinic analysis of eight randomized-controlled clinical trials involving more than 1,100 patients.

1 Mar 2013

Sequester scare touches issues related to Medicare, Medicaid spending

The $85 billion in scheduled spending cuts to defense and discretionary accounts are scheduled to kick in Friday, and movement toward a last-ditch strategy has not been evident.

28 Feb 2013

Inviragen to initiate second stage of DENVax Phase 2 study in dengue

Inviragen, Inc. today announced the initiation of the second stage of an ongoing Phase 2, randomized, double-blind, placebo-controlled study of DENVax, the Company's investigational dengue vaccine.

27 Feb 2013

New research reveals special face masks prevent clinical respiratory and bacterial infections

Health care workers who consistently wear special fitted face masks while on duty are much less likely to get clinical respiratory and bacterial infections, according to new research led by University of New South Wales academics.

27 Feb 2013

Princeton metabolic model can predict how parasites would fare in altered climates

Knowing the temperatures that viruses, bacteria, worms and all other parasites need to grow and survive could help determine the future range of infectious diseases under climate change, according to new research.

27 Feb 2013

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.

From Baxter International Inc. 26 Feb 2013

Polio eradication strategy must be adjusted for local contexts

"It has been a particularly busy couple of months for the Global Polio Eradication Initiative (GPEI)," SciDev.Net Director Nick Ishmael Perkins writes in a SciDev.Net editorial. "The deadly attacks on vaccinators in Pakistan brought renewed global attention to the campaign, and then Bill Gates went public with his personal commitment to end polio," he states, adding, "The GPEI has responded with a strategy for what it calls the 'endgame.'"

26 Feb 2013

Infectious Diseases News and Research

Increased pneumonia rates after Japan earthquake

Discovery provides clues for potentially eliminating HIV infection in children

HIV might promote aging and disease progression in people with HCV, study results suggest

Sanford-Burnham enters into partnership to test furin for treatment of dengue fever

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Sanford Health announces new limb preservation program

Researchers identify smoking gun for environmental exposures to affect future generations

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Idera announces new data from IMO-3100 and IMO-8400 preclinical study on psoriasis

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Griffith University's Institute for Glycomics launches human trials for Streptococcus A vaccine

Steroids may reduce length of hospital stay in patients with pneumonia

Sequester scare touches issues related to Medicare, Medicaid spending

Inviragen to initiate second stage of DENVax Phase 2 study in dengue

New research reveals special face masks prevent clinical respiratory and bacterial infections

Princeton metabolic model can predict how parasites would fare in altered climates

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Polio eradication strategy must be adjusted for local contexts

NGS for Infectious Disease Surveillance eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News